PHIBRO ANIMAL HEALTH CORP Stockholders Equity

Quick Answer

PHIBRO ANIMAL HEALTH CORP reported Stockholders Equity of $285.68 million for the year ending 2025.

  • PHIBRO ANIMAL HEALTH CORP showed an increase of +11.3% in Stockholders Equity from 2024 to 2025.
  • This data is from PHIBRO ANIMAL HEALTH CORP's annual report (Form 10-K), filed with the SEC on August 27, 2025.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: -$78.73 million | Q3 2014: $21.61 million | Q4 2014: $26.04 million | Q1 2015: $23.08 million | Q3 2015: $22.60 million | Q4 2015: $53.31 million | Q1 2016: $77.70 million | Q3 2016: $102.28 million | Q4 2016: $112.61 million | Q1 2017: $139.41 million | Q3 2017: $169.48 million | Q4 2017: $168.33 million | Q1 2018: $185.55 million | Q3 2018: $192.06 million | Q4 2018: $205.22 million | Q1 2019: $213.72 million | Q3 2019: $206.69 million | Q4 2019: $217.42 million | Q1 2020: $195.35 million | Q3 2020: $192.41 million | Q4 2020: $213.32 million | Q1 2021: $215.92 million | Q3 2021: $233.31 million | Q4 2021: $239.29 million | Q1 2022: $266.95 million | Q3 2022: $262.76 million | Q4 2022: $268.37 million | Q1 2023: $272.33 million | Q3 2023: $273.07 million | Q4 2023: $270.80 million | Q1 2024: $270.09 million | Q3 2024: $258.53 million | Q4 2024: $246.80 million | Q1 2025: $265.99 million | Q2 2025: $285.68 million | Q3 2025: $311.68 million | Q4 2025: $332.36 million.
  • Over the full 15 years of available data (2011 to 2025), PHIBRO ANIMAL HEALTH CORP's Stockholders Equity has grown by 513.6%.
  • Historical annual values: Fiscal year 2025: $285.68 million | Fiscal year 2024: $256.64 million | Fiscal year 2023: $282.51 million | Fiscal year 2022: $262.44 million | Fiscal year 2021: $238.53 million | Fiscal year 2020: $188.20 million | Fiscal year 2019: $216.02 million | Fiscal year 2018: $184.95 million | Fiscal year 2017: $151.16 million | Fiscal year 2016: $90.48 million | Fiscal year 2015: $29.63 million | Fiscal year 2014: $15.15 million | Fiscal year 2013: -$68.94 million | Fiscal year 2012: -$88.23 million | Fiscal year 2011: -$69.07 million.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: